Windsor Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$87.5K Hold
10,817
– – 0.02% 132
2026
Q2
$70.6K Hold
10,817
– – 0.02% 127
2026
Q1
$31.8K Hold
10,817
– – 0.01% 123
2025
Q4
$53.8K Hold
10,817
– – 0.01% 121
2025
Q3
$34.1K Hold
10,817
– – 0.01% 121
2025
Q2
$24.4K Hold
10,817
– – 0.01% 120
2025
Q1
$28.9K Hold
10,817
– – 0.01% 118
2024
Q4
$38.1K Hold
10,817
– – 0.01% 119
2024
Q3
$51.3K Buy
+10,817
New +$49.4K 0.01% 119

Other funds holding ACHV

Windsor Capital Management's ACHV Position: Q3 2026 in Review

Windsor Capital Management held its Achieve Life Sciences (ACHV) position steady in Q3 2026 at 10,817 shares worth $87.5K. The position accounts for 0.02% of the portfolio, ranked #132.

Windsor Capital Management first reported a position in ACHV in Q3 2024 and has held it in 9 quarters since. 17 funds tracked by Wall St. Rank hold ACHV as of Q3 2026.

  • Windsor Capital Management held 10,817 shares of Achieve Life Sciences worth $87.5K as of Q3 2026.
  • Windsor Capital Management left its Achieve Life Sciences share count unchanged in Q3 2026.
  • Achieve Life Sciences made up 0.02% of Windsor Capital Management's portfolio in Q3 2026, its #132 holding.
  • Windsor Capital Management first reported a position in Achieve Life Sciences in Q3 2024 and has held it in 9 quarters since.
  • 17 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on Windsor Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.